Photo credit: Novartis /Creative Commons
1. During the company’s earnings call on Tuesday, Novartis CEO Joe Jimenez said that he expects the U.S. pricing environment for prescription drugs to further deteriorate in the years ahead. (Reuters)
2. Purdue Pharma offered rebates to pharmacy benefit managers in 2001 that effectively circumvented prior authorizations for oxycodone. West Virginia state officials required prior authorizations for the drug after noticing a surge in deaths attributed to the painkiller. (STAT)
3. Allergan debuted a new direct-to-consumer campaign, Profiles in Focus, for its chin injection Kybella. The company tapped a photographer and life coach to help consumers look their best in social media profile photos.
4. Express Scripts received subpoenas on September 12 over its relationship with pharmaceutical companies, charities, and specialty pharmacies. The disclosure was made in a regulatory filing on Tuesday. (Reuters)
5. MM&M and sister magazine PRWeek today rolled out the first phase of the Health Influencer 50, a list of 50 battle-tested pros who are changing the healthcare game. Check back every day for the next five days to find out if you made the list. (MM&M)
